Yuvafem

Primary Uses

Yuvafem is primarily prescribed to treat moderate to severe symptoms of vulvar and vaginal atrophy caused by menopause. These symptoms occur when the body produces less estrogen, leading to thinning, drying, and inflammation of the vaginal walls.

Specific conditions treated by Yuvafem include:

• Atrophic vaginitis: Inflammation of the vagina due to thinning tissues and decreased lubrication.
• Kraurosis vulvae: A condition involving dryness and shrinking of the vulva.

Symptom Relief

This medication is used to manage several uncomfortable symptoms associated with these conditions, such as:

• Vaginal dryness or soreness.
• Itching or burning in the genital area.
• Painful sexual intercourse (dyspareunia).
• Urinary symptoms related to vaginal atrophy, such as urgency or painful urination.

Yuvafem provides local estrogen therapy, meaning it works directly on the vaginal tissues to help restore their normal structure and function.

Mechanism of Action

Yuvafem contains estradiol, which is a naturally occurring form of the female hormone estrogen. During menopause, the body produces less estrogen, which can lead to changes in the vaginal area. These changes often include thinning, drying, and inflammation of the vaginal walls, a condition known as atrophic vaginitis.

When the insert is placed in the vagina, it releases a small amount of estradiol locally. This hormone works by:

• Restoring vaginal tissue: Estradiol helps to thicken and maintain the health of the vaginal lining.
• Improving lubrication: It helps the tissues remain moist and elastic, which can reduce discomfort and pain during intercourse.
• Maintaining pH balance: It helps maintain the natural acidic environment of the vagina, which is important for overall vaginal health.

Because the medication is applied locally, it primarily targets the vaginal tissues rather than circulating throughout the entire body in high concentrations.

Common Side Effects

Many people using Yuvafem experience mild side effects. These may include:

• Headache
• Breast pain or tenderness
• Stomach cramps, bloating, or nausea
• Back pain
• Vaginal discharge, itching, or burning
• Cold symptoms, such as a stuffy nose or sore throat

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Signs of a blood clot: Sudden shortness of breath, chest pain, or pain and swelling in one leg.
• Signs of a stroke: Sudden numbness or weakness (especially on one side of the body), severe headache, slurred speech, or vision problems.
• Unusual vaginal bleeding: Any unexpected spotting or heavy bleeding.
• Breast changes: New lumps or changes in the breast tissue.
• Liver problems: Yellowing of the skin or eyes (jaundice), dark urine, or severe upper stomach pain.
• High calcium levels: Confusion, increased thirst, frequent urination, or bone pain.

Seek emergency medical help if you have signs of an allergic reaction, such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Boxed Warnings

Estrogen-alone therapy, such as Yuvafem, is associated with several serious health risks that require careful consideration:

• Endometrial Cancer: There is an increased risk of endometrial cancer in women with a uterus who use estrogens without a progestogen. Healthcare providers typically monitor for any undiagnosed persistent or recurring abnormal vaginal bleeding.
• Cardiovascular Disorders: Estrogens should not be used to prevent heart disease or strokes. Clinical studies have indicated an increased risk of stroke and deep vein thrombosis (DVT) in postmenopausal women.
• Dementia: Estrogens should not be used to prevent dementia. Research has shown an increased risk of developing probable dementia in postmenopausal women aged 65 years or older.

Contraindications

Yuvafem should not be used by individuals with certain medical histories or conditions, including:

• Undiagnosed abnormal genital bleeding.
• Known, suspected, or a history of breast cancer.
• Known or suspected estrogen-dependent neoplasia (tumors).
• Active or past history of deep vein thrombosis or pulmonary embolism.
• Active or recent arterial thromboembolic disease, such as a heart attack or stroke.
• Liver impairment or disease.
• Known or suspected pregnancy.

General Precautions

Healthcare providers monitor for several other potential complications during estrogen therapy:

• Gallbladder Disease: There is an increased risk of gallbladder disease requiring surgery in postmenopausal women receiving estrogens.
• Visual Abnormalities: Treatment may need to be discontinued if there is a sudden loss of vision, or the onset of proptosis, diplopia, or migraine.
• Blood Pressure: Some individuals may experience a significant increase in blood pressure during estrogen replacement therapy.
• Hypertriglyceridemia: In women with pre-existing elevated triglycerides, estrogen therapy may lead to further elevations, which can occasionally cause pancreatitis.
• Fluid Retention: Estrogens may cause fluid retention; therefore, caution is advised for individuals with conditions that might be influenced by this, such as cardiac or renal dysfunction.
• Thyroid Function: Estrogen use may interfere with thyroid hormone levels, potentially requiring adjustments in thyroid replacement therapy doses.

Pregnancy

Yuvafem should not be used during pregnancy. If you suspect you are pregnant or become pregnant while using this medication, you should stop treatment and contact a healthcare provider immediately. While studies of women who inadvertently used estrogens and progestogens from oral contraceptives during early pregnancy have generally not shown an increased risk of birth defects, there is no known medical need for estrogen therapy during pregnancy.

Breastfeeding

Estrogens can pass into breast milk and may decrease the quantity and quality of milk produced. Because of the potential for the medication to be excreted in human milk and its effects on lactation, individuals who are breastfeeding should consult with their healthcare provider to discuss whether to continue or discontinue the medication.

Available Forms

Yuvafem is supplied as a vaginal insert in the following form:

• Vaginal Tablet: A small, film-coated tablet intended for use inside the vagina.

The tablets are provided in blister packs. Each tablet comes with a single-use, disposable applicator to assist with insertion.

FDA Approval and Indications

Yuvafem is approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrophic vaginitis and kraurosis vulvae. These conditions involve the thinning, drying, and inflammation of the vaginal walls due to the body having less estrogen, which typically occurs during menopause.

Boxed Warning

The FDA has issued a boxed warning for Yuvafem, which is the most serious type of warning for a prescription medication. This warning includes the following risks:

• Endometrial Cancer: There is an increased risk of endometrial cancer in women with a uterus who use estrogens without a progestin.
• Cardiovascular Disorders: Estrogen therapy should not be used to prevent heart disease or stroke. It may increase the risk of stroke and deep vein thrombosis (DVT).
• Dementia: There is an increased risk of probable dementia in postmenopausal women aged 65 years and older.
• Breast Cancer: The use of estrogen-plus-progestin therapy has been shown to increase the risk of invasive breast cancer.

Regulatory Status and Use

Yuvafem is available by prescription only. Because of the potential risks associated with estrogen therapy, the FDA recommends that it be prescribed at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual patient. Patients should be re-evaluated periodically to determine if treatment is still necessary.

Insurance and Pharmacy Pricing

The price of Yuvafem is primarily determined by your health insurance plan and the pharmacy you choose. Because Yuvafem is a generic version of Vagifem, it is often more affordable than the brand-name product. Most insurance providers include generic estradiol inserts on their formularies, though the specific tier and copayment will vary.

Out-of-Pocket Considerations

For individuals paying without insurance, the cost may be higher. Retail prices can fluctuate based on the quantity prescribed and the location of the pharmacy. Patients are encouraged to check with multiple pharmacies or use prescription discount tools to find the most competitive price. Some manufacturers or third-party organizations may offer savings programs to help reduce the financial burden for eligible patients.